Medivir AB announces that Linda Basse, Chief Medical Officer at Medivir, will leave the company on September 30, 2020.
Linda Basse has a PhD in medicine (Copenhagen University) and a Master’s degree in medicine (Copenhagen University).
Basse joined Medivir in 2018 and before that she was Medical Director at Genmab, TopoTarget and Zealand Pharma in the development and research fields. She has also been Medical Manager in the medical marketing field at Abbott Denmark, and an advisor at Novo Nordisk and Nycomed.
A recruitment process to find a new Chief Medical Officer will be initiated.